NOTICES 
53711 
53712 
RECOMBINANT DNA MOLE CULE 
PROGRAM ADVISORY COMMITTEE 
Meeting 
Pursuant to Pub. L. 92-463, notice is 
hereby given of the meeting of the Re- 
combinant DNA Molecule Program Advi- 
sory Committee on January 15-16. 1977, 
9 am., at the Sheraton-Four Ambassa- 
dors Hotel, Courier-Emissary Room, 
Tower I, Miami. Florida. This meeting 
will be open to the public on January 15, 
from 9 a.m. to 5 pm., and January 16, 
from 9 a m. to 3 pn to dismiss: guide- 
lines for research Involving recombinant 
DNA molecules, the status of research in 
the field, research studies required, the 
mechanisms by which such studies 
should be supported, and the identifica- 
tion of facilities and resources needed 
in their performance. Attendance by the 
public will be limited to space available. 
In accordance with the provisions set 
forth In sections 552(b)(4), 552(b)(5) 
and 552(b)(6), Title 5. U.S. Code and 
section 10(d) of Pub. L. 92-463, the meet- 
ing will be closed to the public on Janu- 
ary 16 from 3 p m. to 5 pm. for the re- 
view. discussion and evaluation of initial 
pending and renewal grant applications. 
The closed portion of the meeting In- 
volves solely the internal expression of 
views and judgments of committee mem- 
bers on individual grant applications 
containing detailed research protocols, 
designs, and other technical Information: 
financial data, such as salaries: and per- 
sonal Information concerning Individ- 
uals associated with the applications. 
Dr. William J. Gartland. Executive 
Secretary, National Institutes of Health. 
Building 31, Room 4A52, Bethesda, 
Maryland 20014, telephone (301) 496- 
2323, will provide summaries of the 
meetings, rosters of committee members 
and substantive program information. 
Dated: November 29, 1976. 
Suzanne L. Fremeau. 
Committee Management Office, NIH. 
[FR Doc .76-38006 Filed 12-7-76:8:45 am] 
FEDCRAl REGISTER, VOl. 41, NO. 237 — WEDNESDAY, DECEMBER R, 1976 
[ 579 ] 
